Port Delivery System Release Is Predictable, Tailorable for nAMD Treatment – HCPLive
The recently approved novel port delivery system (PDS) for ranibizumab (Lucentis) was shown to provide a consistent, predictable and even … Read source
Click to rate this post!
[Total: 0 Average: 0]